scorecardresearch
Add as a preferred source on Google
Saturday, November 29, 2025
TopicSerum Institute India

Topic: Serum Institute India

UK says Oxford vaccine review ongoing, won’t be approved until safety, efficacy standards met

UK's Medicines and Healthcare products Regulatory Agency tells ThePrint vaccine review includes poring over pages of lab data. If cleared, it will likely boost chances of the vaccine's approval in India.

UK likely to approve Oxford Covid vaccine by year-end, may help boost its chances in India

The trials for the vaccine in India are being carried out by Serum Institute of India (SII) and the company has applied for its emergency authorisation use.

Govt expert panel asks Serum Institute to revise protocol for trial of Novavax Covid vaccine

The company has been asked to submit the safety data of M1 adjuvant — the patented technology of Novavax made to enhance the immune response — along with published literature.

Govt should protect vaccine makers against all lawsuits — Adar Poonawalla

Speaking at the Global Technology Summit 2020 organised by Carnegie India, Poonawalla said the government can intervene and protect vaccine manufacturers from 'frivolous claims'.

Expert panel seeks additional data on Covid vaccines from Serum Institute, Bharat Biotech

The applications of Bharat Biotech and Serum Institute of India are under consideration, while that of the Indian arm of Pfizer has not yet been taken up.

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

Govt begins internal review of Pfizer and Serum Covid vaccines, focus on safety & quality

The recommendations on granting of authorisation will be made on three parameters — safety, quality and efficacy. The Drug Controller General of India will take the final decision.

Serum Institute seeks emergency use approval for Oxford Covid vaccine Covishield in India

According to the ICMR, Serum Institute of India has already manufactured 40 million doses of the vaccine under the at-risk manufacturing and stockpiling license obtained from DCGI.

Govt never spoke about vaccinating entire country against Covid, says health secretary

ICMR chief Dr Balram Bhargava says the idea is to reach a ‘critical mass’, which refers to a point when there are enough people who have been vaccinated to break transmission chain.

Our Covid vaccine is safe, trial volunteer ‘incident’ unfortunate, Serum Institute says

The Serum Institute says the vaccine, Covishield, won’t be released for mass use unless it is proven to be immunogenic and safe.

On Camera

‘Delhi winters’ is a legend. Now it’s just air anxiety

The wealthy float above the crisis—insulated in air-purified cars, weekend getaways at farmhouses, and vacations timed perfectly to coincide with Delhi’s worst weeks.

Karnataka startups feel the chill as global funding winter sets in. Fintech emerges as sole bright spot

The state raises just $2.7 billion in first nine months of 2025 compared to $4.5 billion last year, with late-stage investments hit hardest.

What’s expected from Putin’s India visit in December—Defence Secretary explains

ThePrint had previously reported that India & Russia are talking about 5 more regiments of the S-400, but no contracts are to be signed during the Russian president's visit.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.